Journal home
Advance online publication
Current issue
Archive
Press releases
Supplements
Focus
Guide to authors
Online submissionOnline submission
Permissions
For referees
Free online issue
Contact the journal
Subscribe
Advertising
work@npg
naturereprints
About this site
For librarians
Press release

Please quote Nature Structural Biology as the source of these items.

The January 2002 issue of Nature Structural Biology is available online.

 January 2002 Previous | Next

What may trigger adrenocortical cancer in brazilian children

Nature Structural Biology pp 12 - 16

The high incidence of childhood adrenocortical cancer in Brazil is linked to a specific mutation in the tumor suppressor p53. As reported in the January 2002 issue of Nature Structural Biology, this mutation affects the stability of the tetrameric p53 in a pH-dependent manner. The finding may provide an explanation for the tissue-specific formation of cancer in young children.

The functional form of the tumor suppressor p53 contains four identical subunits. By using a variety of biophysical techniques, Richard Kriwacki and coworkers at St. Jude children's hospital, USA, studied the stability of the p53 domain that is responsible for maintaining the tetrameric organization. They found that when this domain contains a particular mutation (from an arginine to a histidine at position 337), it forms a stable tetramer in a neutral or acidic environment but is unfolded at slightly basic pH values. The authors suggest that the cells in the developing adrenal gland of a child may represent a basic environment, which would destabilize the mutant tetrameric p53; the loss of tumor suppression function in these cells would then lead to cancer formation in the tissue.


A novel mechanism of tumorigenesis involving pH-dependent destabilization of a mutant p53 tetramer pp 12 - 16
Enrico L. DiGiammarino, Amanda S. Lee, Craig Cadwell, Weixing Zhang, Brian Bothner, Raul C. Ribeiro, Gerard Zambetti & Richard W. Kriwacki
Published online: 26 November 2001 | doi:10.1038/nsb730
Abstract | Full text | PDF
Top

Structure of an enzyme targeted in neurological disease treatment

Nature Structural Biology pp 22 - 26

The structure of human monoamine oxidase B (MAO B), a target for the treatment of a variety of neurological diseases, is reported in the January 2002 issue of Nature Structural Biology. This mitochondrial membrane-bound protein, which functions in the oxidative deamidation of neurotransmitters, has been found at increased levels in Alzheimer's patients. Inhibitors of MAO B are used in the treatment of Parkinson's disease and depression and are in clinical trials for the treatment of Alzheimer's disease.

The first structure of this important enzyme has now been solved by Dale Edmondson and colleagues at Emory University in Georgia and the University of Pavia in Italy. The structure reveals the details of the regions of MAO B responsible for catalysis and membrane binding. These results may help guide the design of the next generation of inhibitors for use in the treatment of disease.


Structure of human monoamine oxidase B, a drug target for the treatment of neurological disorders pp 22 - 26
Claudia Binda, Paige Newton-Vinson, Frantisek Hub�lek, Dale E. Edmondson & Andrea Mattevi
Published online: 26 November 2001 | doi:10.1038/nsb732
Abstract | Full text | PDF
Top
Register-TOCRegister for table of contents e-alerts
RecommendRecommend to your library
ReceiveReceive news feeds
what is a news feed?

naturejobs

natureproducts

Search buyers guide:

 
ADVERTISEMENT
 
Nature Structural & Molecular Biology
ISSN: 1545-9993
EISSN: 1545-9985
Journal home | Advance online publication | Current issue | Archive | Press releases | Supplements | For authors | Online submission | Permissions | For referees | Free online issue | About the journal | Contact the journal | Subscribe | Advertising | work@npg | naturereprints | About this site | For librarians
Nature Publishing Group, publisher of Nature, and other science journals and reference works©1998 - 2007 Nature Publishing Group | Privacy policy